Haemolytic uraemic syndrome during treatment with ketorolac trometamol.
Randi
M L
ML
Institute of Medical Semeiotics, Padua University School of Medicine, Padova, Italy.
Tison
T
T
Luzzatto
G
G
Girolami
A
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D020911:Ketorolac Tromethamine; D008875:Middle Aged; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*; D014325:Tromethamine / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014046:Tolmetin